| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Medical Officer | Restricted Stock Unit | 22,667 | $270,722 | $7.96 | 30 Jan 2026 | Direct |
| ZEVRA THERAPEUTICS, INC. | Chief Medical Officer | Common Stock | 9,723 | $85,874 | $8.83 | 30 Jan 2026 | Direct |
| ZEVRA THERAPEUTICS, INC. | Chief Medical Officer | Stock Option (right to buy) | 75,000 | 29 Jan 2026 | Direct | ||
| Acer Therapeutics Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 30,000 | 14 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | 29 Jan 2026 | 5 | -$40,036 | 4 | Chief Medical Officer | 02 Feb 2026, 17:19 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 30 Jan 2025 | 2 | $0 | 4 | Chief Medical Officer | 27 Mar 2025, 20:31 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 06 Dec 2024 | 0 | $0 | 3 | Chief Medical Officer | 27 Mar 2025, 20:30 |
| /report/000120919123019339-quartel-adrian-w-2023-03-14 | Acer Therapeutics Inc. | 14 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 16 Mar 2023, 16:50 |
| /report/000120919122012249-quartel-adrian-w-2022-02-21 | Acer Therapeutics Inc. | 21 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 23 Feb 2022, 15:39 |
| /report/000120919122012242-quartel-adrian-w-2022-02-21 | Acer Therapeutics Inc. | 21 Feb 2022 | 0 | $0 | 3 | Chief Medical Officer | 23 Feb 2022, 15:37 |